Rosiglitazone is pretty much dead. Here’s the eulogy at the FDA website. Rare is the doctor who will jump through all the paperwork hoops when we have 10 other classes of drugs to treat diabetes, plus another, safer drug in the thiazolidinedione class.
Rosiglitazone is linked to higher rates of heart disease and death.
Steve Parker, M.D.
2 responses to “R.I.P., Rosiglitazone”
Pingback: Diabetic Drug Pioglitazone Linked to Bladder Cancer | Diabetic Mediterranean Diet
Pingback: Oral Drugs for Type 2 Diabetes: Which Are The Best? | Diabetic Mediterranean Diet